Propanc Biopharma, Inc. Stock Analysis & AI Score
Propanc Biopharma, Inc. (PPCB) has an ST Score of 26.8 (D+), driven by its Growth (A+) and held back by its Momentum (F). PPCB last traded at $0.60.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Propanc Biopharma, Inc. (PPCB) has an ST Score of 26.8 (D+), driven by its Growth (A+) and held back by its Momentum (F). PPCB last traded at $0.60.
- Strongest
- GrowthA+
- Weakest
- MomentumF
All factor grades
- GrowthA+
- ValuationC
- Financial StrengthD-
- ProfitabilityF
- MomentumF
- Piotroski2/9
Contact
PPCB stock: frequently asked questions
What is PPCB's ST Score?
Propanc Biopharma, Inc. (PPCB) has an ST Score of 26.8 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PPCB a buy, hold, or sell?
Our ST Score grades it D+ (26.8/100). The ST Score is a data-driven signal, not a recommendation.
What are PPCB's factor grades?
Valuation C, Profitability F, Financial Strength D-, Momentum F, Growth A+.
What is PPCB's valuation grade?
Propanc Biopharma, Inc. (PPCB) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PPCB's growth grade?
Propanc Biopharma, Inc. (PPCB) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PPCB's profitability grade?
Propanc Biopharma, Inc. (PPCB) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PPCB's financial strength grade?
Propanc Biopharma, Inc. (PPCB) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is PPCB's Piotroski score?
Propanc Biopharma, Inc. (PPCB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.